Turning an Unlit Corner On

Fasolati started with a simple observation in an operating room: the mouth and the body have never been treated as one connected system. We're changing that.

The Origin

From the OR to the Operating System

For nearly two decades, Dr. Thad Connely has operated at the intersection of the mouth and the body — as an oral and maxillofacial surgeon performing total joint reconstructions, treating the most severe manifestations of what happens when oral disease goes systemic.

The pattern was always the same: patients arriving with advanced disease that started as inflammation nobody monitored. Periodontitis that seeded systemic infection. Gut dysbiosis that accelerated joint destruction. Biomarkers that were never checked until the damage was done.

The insight wasn't that these systems were connected — the literature has shown that for decades. The insight was that nobody had built the infrastructure to treat them as one system. No product line spanned both origin nodes. No AI correlated the data across domains. No protocol existed that told a patient what to rinse, swallow, and avoid — today, based on their specific inflammatory profile.

Fasolati is that infrastructure. Built by a surgeon who got tired of operating on problems that should have been intercepted upstream.

The Mission

Make Inflammation Visible, Controllable, and Preventable

Three out of five people die of chronic inflammatory diseases. The mouth and the gut are the two origin nodes where that inflammation begins — and the two places where it can actually be intercepted before it becomes cardiovascular disease, neurodegeneration, metabolic syndrome, or autoimmune destruction.

Treat the Network, Not the Symptom

The body is a connected system. Oral health, gut health, and systemic inflammation are not three separate problems — they're one network. Fasolati is built to treat the network.

Protocols Over Advice

Vague wellness recommendations fail. Specific, daily, data-driven protocols succeed. SciAgent doesn't suggest you "eat better" — it tells you exactly what to do today based on your data.

Surgeon-Grade Science, Patient-Grade Access

The same mechanisms used in the operating room — enzymatic biofilm disruption, phage therapy, HA tissue engineering — delivered as daily consumer products anyone can use.

Transparency as Architecture

Every recommendation comes with a "why." Every data point is yours. Every algorithm is auditable. We built "Inside the Black Box" because trust isn't a feature — it's the foundation.

The Journey

Milestones

2006–2015

Clinical Foundation

Nearly a decade of oral and maxillofacial surgery across thousands of cases. Pattern recognition: the mouth-body disconnect in clinical practice is systemic, not anecdotal. The problem isn't knowledge — it's infrastructure.

2016–2019

Oral Formulation Development

Development of the dual-weight hyaluronic acid platform. First prototypes of what would become Loria — a chlorhexidine replacement that heals instead of kills. Early clinical validation of the mucosal barrier approach.

2020–2022

From Product to Platform

The realization that a single oral rinse wasn't enough. The mouth-gut-systemic framework takes shape. Partnerships with Magisnat (nutraceuticals), phage therapy researchers, and the Mata lab at Nottingham for enamel regeneration.

2023–2024

Fasolati Architecture

The platform crystallizes: two oral product lines (Lytica, Loria), three gut products (Magisnat, Biolumen, Monch Monch), two distribution tiers (Maxoral Rx, Fasolati OTC), and the SciAgent AI engine tying it all together.

2025

ELR Breakthrough

Mata's ELR enamel regeneration technology published in Nature Communications. A significant advance in biomimetic enamel reconstruction research.

2026

Node Network Launch

Loria goes to market. Fasolati Engine enters beta. DSO partnerships activate. The node network goes from architecture to operating system. The unlit corner starts to glow.

Partner With Us View Deep Dive